Nav: Home

MDA associated with the prevention of a resurgence of malaria in Greece

November 19, 2015

Greece was declared malaria free in 1974, however, in 2011 a resurgence of P. vivax malaria was seen in Southern Greece in connection with the presence of agricultural workers from malaria-endemic regions in malaria receptive areas. Standard control measures were implemented for one year (i.e. Active case detection, intensifies vector control), after which a program of mass drug administration (MDA) was implemented to provide the entire local immigrant population with a curative course of antimalarial drugs. No malaria cases were reported for the years 2013-2014, when the MDA was on-going.

Since 1974 with only a small and sporadic number of malaria cases have been reported in Greece. However in 2011, 21 P. vivax cases from arriving immigrants were reported in the Southern agricultural area of Evrotas, along with 36 local cases. An integrated control program was immediately implemented, with house visits established to screen immigrants from endemic countries. Screening included a rapid diagnostic test for those reporting compatible symptoms along with blood sampling for smear and molecular testing for malaria. Directly Observed treatment was provided for all who tested positive. A vector control program was also implemented, with indoor residual spraying and long-lasting insecticide nets provided in areas close to mosquito breeding sites.

Despite these interventions 20 more introduced cases were reported in 2012 and, due to fears that the malaria parasite may be re-establishing in the area, a program of mass drug administration of one course of chloroquine and primaquine, which are the first line recommended antimalarials for P. vivax. Adverse events were recorded and managed daily. The program was implemented prior to the onset of peak adult mosquito activity and field teams remained in situ continuing the Active Case Detection until the end of the mosquito season.

An immigrant population of 1270 persons was identified, mostly from Pakistan and Afghanistan. MDA covered 87% of this population. Of the treated individuals 13% reported gastrointestinal symptoms from primaquine, while 36% reported non-severe side effects from chloroquine including headaches, dizziness and gastrointestinal complaints. One potentially serious adverse event was recorded; a case of primaquine-induced hemolysis due to a false normal G6PD level obtained prior to enrollment. The patient was hospitalized and recovered fully.

In this case, mass drug administration was a suitable and effective response for a small and geographically confined population over a short seasonal transition period. The combination of two drugs minimizes the risk of drug resistance. Although an observational study of this nature cannot assess the extent to which mass drug administration was responsible for eliminating malaria, it certainly indicates that mass drug administration should be considered and can be effective in local settings alongside other malaria control measures.
-end-
Please contact plosntds@plos.org if you would like more information about our content and specific topics of interest.

All works published in PLOS Neglected Tropical Diseases are open access, which means that everything is immediately and freely available. Use this URL in your coverage to provide readers access to the paper upon publication:

http://dx.plos.org/10.1371/journal.pntd.0004215 (Link goes live upon article publication)

Press-Only Preview Of The Article:https://www.plos.org/wp-content/uploads/2015/11/pntd.0004215.pdf

Contact: Christos Hadjichristodoulou, 0030 2410 565050, xhatzi@med.uth.gr

Funding: The data collected in the context of "Integrated Surveillance and control programme for West Nile Virus and malaria in Greece MIS 365280 (MALWEST Project )" which is implemented through the Operational Programme entitled "Human Resources Development" of National Strategic Reference Framework" (NSRF) 2007-2013. The programme is co-funded by Greece and the European Union--European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

About PLOS Neglected Tropical Diseases

PLOS Neglected Tropical Diseases is a peer-reviewed, open-access journal devoted to the pathology, epidemiology, prevention, treatment, and control of the neglected tropical diseases, as well as public policy relevant to this group of diseases. All works published in PLOS Neglected Tropical Diseases are open access, which means that everything is immediately and freely available subject only to the condition that the original authorship and source are properly attributed. The Public Library of Science uses the Creative Commons Attribution License, and copyright is retained by the authors.

About the Public Library of Science

The Public Library of Science (PLOS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org.

Media Permissions

PLOS Journals publish under a Creative Commons Attribution License, which permits free reuse of all materials published with the article, so long as the work is cited (e.g., Kaltenbach LS et al. (2007) Huntington Interacting Proteins Are Genetic Modifiers of Neurodegeneration. PLOS Genet 3(5): e82. doi:10.1371/journal.pgen.0030082). No prior permission is required from the authors or publisher. For queries about the license, please contact the relative journal contact indicated here: http://www.plos.org/journals/embargopolicy.php

PLOS

Related Malaria Articles:

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Seeking better detection for chronic malaria
In people with chronic malaria, certain metabolic systems in the blood change to support a long-term host-parasite relationship, a finding that is key to eventually developing better detection, treatment and eradication of the disease, according to research published today in the Journal of Clinical Investigation Insight.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
Certain antibodies against a sugar are associated with malaria protection
Certain type of antibodies against α-Gal- a carbohydrate expressed by many organisms including the malaria parasite- could protect against malaria, according to a new study led by ISGlobal, an institution supported by 'la Caixa' Foundation.
More Malaria News and Malaria Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.